beta-blocking agents
Clinical        trials have shown that beta-blocking agents increase left ventricular ejection       fraction and reduce left ventricular dimensions in patients with HF, indicating       regression of left ventricular remodelling.
Clinical        trials have shown that  @SUBJECT$  increase left ventricular ejection       fraction and reduce left ventricular dimensions  @PREDICAT$   @OBJECT$  with HF, indicating       regression of left ventricular remodelling.